AU8533101A - Phosphate derivatives as immunoregulatory agents - Google Patents

Phosphate derivatives as immunoregulatory agents

Info

Publication number
AU8533101A
AU8533101A AU8533101A AU8533101A AU8533101A AU 8533101 A AU8533101 A AU 8533101A AU 8533101 A AU8533101 A AU 8533101A AU 8533101 A AU8533101 A AU 8533101A AU 8533101 A AU8533101 A AU 8533101A
Authority
AU
Australia
Prior art keywords
phosphate derivatives
immunoregulatory agents
immunoregulatory
agents
phosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU8533101A
Inventor
Suzanne Mandala
James Bergstrom
Richard Hajdu
Hugh Rosen
William H Parsons
Deborah J Card
Malcolm Maccoss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Merck Sharp and Dohme Corp
Original Assignee
Merck and Co Inc
Merck Sharp and Dohme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US22943800P priority Critical
Application filed by Merck and Co Inc, Merck Sharp and Dohme Corp filed Critical Merck and Co Inc
Priority to PCT/US2001/026789 priority patent/WO2002018395A1/en
Publication of AU8533101A publication Critical patent/AU8533101A/en
Application status is Pending legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/094Esters of phosphoric acids with arylalkanols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3882Arylalkanephosphonic acids
AU8533101A 2000-08-31 2001-08-28 Phosphate derivatives as immunoregulatory agents Pending AU8533101A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US22943800P true 2000-08-31 2000-08-31
PCT/US2001/026789 WO2002018395A1 (en) 2000-08-31 2001-08-28 Phosphate derivatives as immunoregulatory agents

Publications (1)

Publication Number Publication Date
AU8533101A true AU8533101A (en) 2002-03-13

Family

ID=22861252

Family Applications (2)

Application Number Title Priority Date Filing Date
AU8533101A Pending AU8533101A (en) 2000-08-31 2001-08-28 Phosphate derivatives as immunoregulatory agents
AU2001285331A Ceased AU2001285331B2 (en) 2000-08-31 2001-08-28 Phosphate derivatives as immunoregulatory agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001285331A Ceased AU2001285331B2 (en) 2000-08-31 2001-08-28 Phosphate derivatives as immunoregulatory agents

Country Status (6)

Country Link
US (1) US6437165B1 (en)
EP (1) EP1315735A4 (en)
JP (1) JP2004507552A (en)
AU (2) AU8533101A (en)
CA (1) CA2421893A1 (en)
WO (1) WO2002018395A1 (en)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040006242A1 (en) 1999-02-01 2004-01-08 Hawkins Lynn D. Immunomodulatory compounds and method of use thereof
US6551600B2 (en) * 1999-02-01 2003-04-22 Eisai Co., Ltd. Immunological adjuvant compounds compositions and methods of use thereof
US7915238B2 (en) * 1999-02-01 2011-03-29 Eisai R & D Management Co., Ltd. Immunomodulatory compounds and methods of use thereof
US6835721B2 (en) * 1999-02-01 2004-12-28 Eisai Co., Ltd. Immunomodulatory compounds and methods of use thereof
PL359411A1 (en) * 2000-07-13 2004-08-23 Sankyo Company, Limited Amino alcohol derivatives
WO2002029001A2 (en) 2000-10-03 2002-04-11 University Of Virginian Patent Foundation Novel lysophosphatidic acid receptor agonists and antagonists
CA2437358A1 (en) 2001-01-30 2002-08-22 University Of Virginia Patent Foundation Agonists and antagonists of sphingosine-1-phosphate receptors
CZ20032560A3 (en) * 2001-03-26 2003-12-17 Novartis Ag 2-Aminopropanol derivatives, process of their preparation and pharmaceutical composition in which the derivatives are comprised
AU2003202495B2 (en) 2002-01-11 2006-07-20 Sankyo Company, Limited Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
AT448193T (en) * 2002-01-18 2009-11-15 Merck & Co Inc ßN- (BENZYL) AMINOALKYL CARBOXYLATE, PHOSPHINATE, PHOSPHONATE AND TETRAZOLE AS EDG RECEPTOR AGONISTENS
AU2003216054B2 (en) * 2002-01-18 2007-01-04 Merck & Co., Inc. Selective S1P1/Edg1 receptor agonists
US20040058894A1 (en) * 2002-01-18 2004-03-25 Doherty George A. Selective S1P1/Edg1 receptor agonists
JP4430941B2 (en) * 2002-01-18 2010-03-10 メルク エンド カムパニー インコーポレーテッドMerck & Company Incoporated Edg receptor agonist
AU2003217764A1 (en) 2002-03-01 2003-09-16 Merck & Co., Inc. Aminoalkylphosphonates and related compounds as edg receptor agonists
JP2005531508A (en) * 2002-03-01 2005-10-20 メルク エンド カムパニー インコーポレーテッドMerck & Company Incoporated Aminoalkylphosphonates and related compounds as agonists of EDG receptors
WO2003097028A1 (en) 2002-05-16 2003-11-27 Novartis Ag Use of edg receptor binding agents in cancer
GB0217152D0 (en) 2002-07-24 2002-09-04 Novartis Ag Organic compounds
US7612238B2 (en) 2002-09-13 2009-11-03 Novartis Ag Amino-propanol derivatives
CA2498944C (en) 2002-09-19 2011-05-17 Yasushi Kohno Amino alcohol derivatives, salts thereof and immunosuppressive agents
TWI335311B (en) 2002-09-24 2011-01-01 Novartis Ag Organic compounds
WO2004037843A2 (en) * 2002-10-25 2004-05-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
AU2003286389A1 (en) * 2002-11-29 2004-06-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ace-inhibitors having antioxidant and nitricoxid-donor activity
EP2172472B1 (en) 2003-02-18 2012-12-26 Kyorin Pharmaceutical Co., Ltd. Aminophosphonic acid derivative, salt thereof and modulator of S1P receptor
DE122011100047I1 (en) * 2003-04-08 2011-12-15 Mitsubishi Tanabe Pharma Corp Solid pharmaceutical dosage forms containing a S1P receptor agonist and a sugar alcohol.
AU2008200368B2 (en) * 2003-04-08 2011-04-28 Mitsubishi Tanabe Pharma Corporation Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol
AU2011205050B2 (en) * 2003-04-08 2014-01-30 Mitsubishi Tanabe Pharma Corporation Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol
MY150088A (en) 2003-05-19 2013-11-29 Irm Llc Immunosuppressant compounds and compositions
WO2005014603A1 (en) * 2003-08-12 2005-02-17 Mitsubishi Pharma Corporation Phosphinane compounds with immunomodulating activity
AT449069T (en) * 2003-08-28 2009-12-15 Novartis Pharma Gmbh aminopropanol
GB0320638D0 (en) 2003-09-03 2003-10-01 Novartis Ag Organic compounds
GB0329498D0 (en) 2003-12-19 2004-01-28 Novartis Ag Organic compounds
KR20110136901A (en) 2004-02-24 2011-12-21 상꾜 가부시키가이샤 Amino alcohol compound
JP2007536310A (en) * 2004-05-03 2007-12-13 ノバルティス アクチエンゲゼルシャフト Combination comprising S1P receptor agonist and JAK3 kinase inhibitor
WO2005115150A2 (en) 2004-05-06 2005-12-08 University Of Virginia Patent Foundation Novel lysophosphatidic acid receptor selective antagonists
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
US7781617B2 (en) * 2004-07-16 2010-08-24 Kyorin Pharmaceutical Co., Ltd Effective use method of medicaments and method of preventing expression of side effect
US20080096972A1 (en) * 2004-07-30 2008-04-24 Thitiwan Buranachokpaisan Compound formulations of 2-amino-1, 3-propanediol compounds
EP1798226A4 (en) 2004-08-04 2009-06-17 Taisho Pharma Co Ltd Triazole derivative
US20060223866A1 (en) * 2004-08-13 2006-10-05 Praecis Pharmaceuticals, Inc. Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
MX2007001661A (en) * 2004-08-13 2007-04-23 Praecis Pharm Inc Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity.
MX2007004319A (en) * 2004-10-12 2007-06-15 Kyorin Seiyaku Kk Process for producing 2-amino-2-[2-[4-(3-benzyloxy ??phenylthio)-2-chlorophenyl] ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same.
KR20140095109A (en) 2004-11-29 2014-07-31 노파르티스 아게 Dosage regimen of an s1p receptor agonist
GB0500020D0 (en) 2005-01-04 2005-02-09 Novartis Ag Organic compounds
GB0504544D0 (en) 2005-03-04 2005-04-13 Novartis Ag Organic compounds
PL1719507T3 (en) 2005-04-13 2010-12-31 Cipher Pharmaceuticals Inc Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
US20070292418A1 (en) * 2005-04-26 2007-12-20 Eisai Co., Ltd. Compositions and methods for immunotherapy
JP5185813B2 (en) 2005-04-26 2013-04-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 Compositions and methods for cancer immunotherapy
KR20080050591A (en) 2005-09-01 2008-06-09 아레스 트레이딩 에스.에이. Treatment of optic neuritis
US8048928B2 (en) * 2005-10-07 2011-11-01 Kyorin Pharmaceutical Co., Ltd. Therapeutic agent for treating liver disease containing 2-amino-1,3-propanediol derivative as active ingredient, and method for treating liver disease
EP1988083B1 (en) 2006-02-03 2014-04-02 Taisho Pharmaceutical Co., Ltd. Triazole derivative
EP1988081B1 (en) 2006-02-06 2012-10-17 Taisho Pharmaceutical Co., Ltd Binding inhibitor of sphingosine-1-phosphate
TWI389683B (en) * 2006-02-06 2013-03-21 Kyorin Seiyaku Kk A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
SG173368A1 (en) 2006-04-11 2011-08-29 Novartis Ag Peptidic compounds useful in the treatment of hcv and/or hiv infection and related disorders
MX2009001457A (en) * 2006-08-08 2009-02-19 Kyorin Seiyaku Kk Aminoalcohol derivative and immunosuppressant containing the same as active ingredient.
PT2058317E (en) * 2006-08-08 2013-12-11 Kyorin Seiyaku Kk Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient
EP1923054A1 (en) * 2006-09-26 2008-05-21 Novartis AG Fast disintegrating pharmaceutical composition comprising an S1P agonist or modulator
CA2953372A1 (en) 2006-09-26 2008-04-03 Novartis Ag Pharmaceutical composition comprising an s1p receptor modulator
US7801502B2 (en) * 2006-12-18 2010-09-21 Aai Corporation Method for implementing continuous radio frequency (RF) alignment in advanced electronic warfare (EW) signal stimulation systems
PL2177512T3 (en) 2007-08-01 2012-09-28 Taisho Pharma Co Ltd Inhibitor of binding of s1p1
SG10201800085XA (en) 2007-10-12 2018-02-27 Novartis Ag Compositions comprising sphingosine 1 phosphate (s1p) receptor modulators
JP2011502986A (en) * 2007-11-02 2011-01-27 コンサート ファーマシューティカルズ インコーポレイテッド Deuterated fingolimod
US8476305B2 (en) * 2008-02-07 2013-07-02 Kyorin Pharmaceutical Co., Ltd. Therapeutic agent or prophylactic agent for inflammatory bowel disease comprising amino alcohol derivative as active ingredient
AU2009276343A1 (en) 2008-08-01 2010-02-04 Bioxiness Pharmaceuticals, Inc. Methionine analogs and methods of using same
CA2747802A1 (en) 2008-12-22 2010-07-01 Novartis Ag Dosage regimen for a s1p receptor agonist
US20110182850A1 (en) 2009-04-10 2011-07-28 Trixi Brandl Organic compounds and their uses
US8512690B2 (en) 2009-04-10 2013-08-20 Novartis Ag Derivatised proline containing peptide compounds as protease inhibitors
CA2774047A1 (en) 2009-09-29 2011-04-07 Novartis Ag Method and system for accessing patient data
US8409628B2 (en) 2010-02-04 2013-04-02 Penguin IP Holdings, Inc. Methods and compositions for oxygenation of skin to treat skin disorders
WO2011123619A2 (en) 2010-03-31 2011-10-06 Penguin Ip Holdings Inc. Permeable mixtures, methods and compositions for the skin
CN103179966B (en) 2010-10-08 2017-03-15 诺瓦提斯公司 The Vitamin E preparation of sulfonamide NS3 inhibitor
FR2968556B1 (en) 2010-12-13 2013-12-27 Centre Nat Rech Scient Inhibitors of hiv infections and uses thereof
AR085749A1 (en) 2011-04-01 2013-10-23 Novartis Ag formulations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL36730D0 (en) * 1970-05-28 1971-06-23 Chemagro Corp Phosphonamidothioates,their preparation and their use as herbicides and/or plant growth regulators
DE69321823D1 (en) 1992-10-21 1998-12-03 Yoshitomi Pharmaceutical propanediol compound 2-amino-1, 3- and immunosuppressium
US5948820A (en) 1994-08-22 1999-09-07 Yoshitomi Pharmaceutical Industries, Ltd. Benzene compound and pharmaceutical use thereof
DE69633613T2 (en) 1995-12-28 2006-02-09 Mitsubishi Pharma Corp. A pharmaceutical composition containing 2-amino-2- (2- (4-octylphenyl) ethyl) propane-1,3-diol for the treatment of diseases caused by a disorder of the immune system
JP2002241272A (en) 1996-07-18 2002-08-28 Mitsubishi Pharma Corp Medicinal composition
GB9624038D0 (en) 1996-11-19 1997-01-08 Sandoz Ltd Organic compounds
JPH10147587A (en) 1996-11-19 1998-06-02 Fujisawa Pharmaceut Co Ltd 2-amino-1,3 propanediol derivative and its pharmaceutical use
DE69840169D1 (en) 1997-02-27 2008-12-11 Novartis Ag MEDICAMENT PREPARATION CONTAINING 2-AMINO-2-Ä2- (4-OCTYLPHENYL) ETHYL PROPANE-1,3-DIOL, A LECITHIN AND A Saccharide
WO1999001420A1 (en) 1997-07-03 1999-01-14 Taito Co., Ltd. Process for the preparation of 2-aminomalonic acid derivatives and intermediates used in the process
JPH1134300A (en) 1997-07-18 1999-02-09 Dainippon Printing Co Ltd Printed matter selector and printed matter inspecting apparatus
JPH1180026A (en) 1997-09-02 1999-03-23 Yoshitomi Pharmaceut Ind Ltd New immunosuppressant, its use and its identification
JPH11209277A (en) 1998-01-19 1999-08-03 Yoshitomi Pharmaceut Ind Ltd Pharmaceutical composition
JP4079505B2 (en) 1998-04-28 2008-04-23 田辺三菱製薬株式会社 Novel process for the preparation of 2-amino-2- [2- (4-octylphenyl) ethyl] propane-1,3-diol
AU1161400A (en) 1998-11-11 2000-05-29 Abel, Stephan Production of 2-amino-2-(2-(4-C2-20-alkyl-phenyl)ethyl)propane-1 ,3-diols

Also Published As

Publication number Publication date
AU2001285331B2 (en) 2006-04-06
WO2002018395A1 (en) 2002-03-07
US20020091105A1 (en) 2002-07-11
US6437165B1 (en) 2002-08-20
EP1315735A1 (en) 2003-06-04
CA2421893A1 (en) 2002-03-07
EP1315735A4 (en) 2005-04-06
JP2004507552A (en) 2004-03-11

Similar Documents

Publication Publication Date Title
DE60139107D1 (en) Substituierte phenyl-sulfamoyl-carboxamide
DE60105852D1 (en) Fluidmischsystem
DE60140693D1 (en) Ankheiten
DE60131262D1 (en) Ubiquitin-ligase-assay
DE60123606D1 (en) Transkutane prothese
EG24433A (en) Novel benzolimidazole derivatives useful as antiproliferative agents
GC0000287A (en) Purine derivatives
GB2365486B (en) Karabiners
DE50012997D1 (en) Phosphite
DE60116761D1 (en) Adamantanderivate
GB2352493B (en) Single piece piston
DE60141333D1 (en) Ioxidlösung
DE50110048D1 (en) Härtbare wässrige polyurethandispersionen
EG24669A (en) Antivral azaindole derivatives
DE60116104D1 (en) Phasendispersive tomographie
DE60115621D1 (en) Imidazolcarbene
EG24074A (en) Formulation
EG26726A (en) Glycopertide phosphonate derivatives
AU6010300A (en) Xml-robot
HRP20010665A2 (en) Compounds useful as anti-inflammatory agents
AU5214501A (en) Microcapsules - vi
HRP20020676A2 (en) Purine derivatives
IL154292D0 (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell profiliferation
HRP20020175A2 (en) N-heterocyclikc derivatives as nos inhibitors
GB0018828D0 (en) Alkyl Amino Acid Derivatives useful as pharmaceutical agents